The Life Sciences Leader's Guide to AWS Cloud Migration in the UK

Why Life Sciences Cloud Migration Is Different

For most industries, cloud migration is primarily a technical exercise — lift and shift, re-platform, or re-architect. For life sciences organisations, migration is also a regulatory event. Any computerised system used in a GxP process that is migrated to a new infrastructure must be re-validated in its new environment. Change control documentation is required. Risk assessments must be conducted. Users must be retrained. Validation evidence must demonstrate the system performs its intended function in the AWS environment.

This means a life sciences cloud migration requires the same rigorous discipline as any other GxP system change — but at cloud scale, with the complexity of multiple interconnected systems, data volumes, and compliance frameworks. Done well, migration delivers transformational benefits. Done poorly, it creates regulatory risk and operational disruption.

The Business Case for Migration

Despite the complexity, the business case for migrating life sciences workloads to AWS is compelling:

• Infrastructure cost reduction: Eliminating on-premises hardware, data centre costs, and maintenance contracts typically delivers 30–50% total cost of ownership reduction over three years
• Operational agility: Elastic compute for peak research periods (clinical trial data ingestion, genomics processing) without permanent over-provisioning
• Disaster recovery: AWS Multi-AZ and Cross-Region architectures provide recovery point objectives (RPO) and recovery time objectives (RTO) that would be cost-prohibitive on-premises
• Innovation velocity: Access to managed AI/ML services (SageMaker, Bedrock), serverless computing, and 200+ AWS services that accelerate product development
• Compliance posture: AWS provides pre-built compliance frameworks (GxP, HIPAA, ISO 27001) and continuous compliance monitoring that is difficult to replicate on-premises

Phase 1: Discovery and Assessment

A successful life sciences migration begins with a thorough discovery phase — typically 4–6 weeks. This covers application portfolio inventory (identifying all systems and their GxP classification), dependency mapping (understanding system interconnections that constrain migration sequencing), current infrastructure baseline (capacity, performance, licensing), data classification (regulated vs non-regulated, personal data, confidential), and current compliance posture (existing validation documentation, known gaps).

The output is a migration portfolio assessment that classifies each system by: migration strategy (rehost, re-platform, re-architect, retire, retain), GxP validation requirement (full CSV, light-touch, or none), migration complexity (low/medium/high), and recommended migration sequence.

Phase 2: Cloud Foundation Design

Before migrating any workload, a secure, compliant AWS Landing Zone must be established. For life sciences, this means a multi-account structure (separate accounts for production GxP, development/test, and non-GxP workloads), a dedicated GxP VPC architecture with private subnets and no direct internet access, centralised logging to an immutable audit account, AWS CloudTrail with log file integrity validation across all accounts, AWS Config with GxP compliance rules deployed, and IAM Identity Centre for federated user access with MFA enforcement.

This foundation is itself a validated deliverable — IQ documentation for the landing zone must be produced and approved before any GxP systems migrate into it.

Phase 3: Validation Strategy

The validation strategy defines the documentation approach for each system migration. For a LIMS migration, this typically requires: an updated URS confirming the system's intended use is unchanged; an IQ documenting the AWS hosting environment configuration; an OQ re-running functional test scripts in the cloud environment; a PQ verifying performance meets specification under production load conditions; and a change control record referencing all validation documentation.

A risk-based approach to validation scope is appropriate and defensible. Systems with low GxP impact (reporting, analytics) may require only a re-IQ. Core GMP systems (MES, batch records, LIMS) require full validation lifecycle documentation.

Phase 4: Data Migration

Data migration in regulated environments requires particular care. All data must be migrated with integrity verification — cryptographic checksums comparing source and destination records. Regulated electronic records must be migrated to storage meeting 21 CFR Part 11 / Annex 11 requirements from day one. A validated migration test environment should be used to test the migration process before production execution. AWS Database Migration Service (DMS) supports most relational database platforms and provides built-in validation checks. S3 transfer with multi-part upload and integrity verification handles large file volumes.

Phase 5: Cutover and Go-Live

The production cutover is the highest-risk phase. Best practices for regulated go-lives include: a weekend or planned maintenance window to minimise operational disruption; a rehearsed cutover runbook with step-by-step procedures and rollback criteria; parallel running of legacy and cloud systems for a defined period (typically 2–4 weeks for critical GxP systems); user acceptance testing in the cloud environment before go-live; and formal sign-off from quality and IT stakeholders before legacy system decommission.

Common Migration Pitfalls in Life Sciences

• Underestimating validation scope: Treating cloud migration as purely a technical change without recognising the CSV implications — the most common source of migration delays
• Change control gaps: Failing to initiate formal change control records before starting migration work on validated systems
• Licence mismatches: Not addressing Windows Server and SQL Server licence compliance in the cloud environment before migration
• Network latency surprises: Validated systems with hard-coded latency expectations that fail performance qualification in the cloud
• Inadequate landing zone: Migrating GxP systems into an under-specified AWS environment that then requires remediation during validation

The skyPurple Approach

skyPurple Cloud's life sciences migration methodology integrates cloud engineering with GxP validation expertise from day one. We produce all required change control documentation, validation plans, and qualification evidence as part of the migration deliverables — not as an afterthought. Our AWS Advanced Partner status and deep life sciences domain expertise means we understand both the technical architecture requirements and the regulatory context, delivering compliant cloud environments that your QA team can qualify with confidence.